United Therapeutics Officer Paul Mahon Files Form 144 to Sell $4.69M Under 10b5-1 Plan
UNITED THERAPEUTICS Corp
Subscribe to track UTHR
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Form 144 Notice: United Therapeutics Corp (UTHR)
**Filer:** Paul Mahon | Officer
**Filing Date:** October 1, 2026
**Proposed Transaction:** Sale of 8,300 Common Shares
**Estimated Value:** $4,689,050.97 (~$564.95/share)
**Trading Significance:** Low (Pre-scheduled Rule 10b5-1 Plan adopted 08/11/2025)
Comprehensive Analysis
Executive Summary
On October 1, 2026, Paul Mahon, an Officer of United Therapeutics Corp (UTHR), filed a Form 144 notice disclosing the intent to sell 8,300 shares of common stock with an aggregate market value of approximately $4.69 million (~$564.95 per share). The transaction is managed by Morgan Stanley Smith Barney LLC.
Transaction & Plan Details
- Nature of Acquisition: Stock option exercise from the issuer paid in cash on October 1, 2026.
- Rule 10b5-1 Plan: The proposed sale is executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on August 11, 2025.
- Pattern of Activity: Filing history demonstrates regular, bi-weekly sales of precisely 8,300 shares across July, August, and September 2026 (07/02, 07/16, 08/06, 08/20, 09/03, 09/17).
Trading Significance
This filing carries Low market significance. The transaction represents routine execution of an established 10b5-1 trading plan consisting of option exercises and scheduled dispositions, showing consistency rather than opportunistic insider sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.